The growth of a strain of Escherichia coli K-12 which possesses only the single isoenzyme 3-deoxy-D-arabinoheptulosonic acid-7-phosphate (DAHP) synthetase (trp), and which makes this enzyme constitutively, is inhibited by tryptophan. The accumulation of DAHP by a derivative of this strain unable to convert DAHP to dehydroquinate is also inhibited by tryptophan. The enzymic activity of DAHP synthetase (trp) in the presence of CO2+ is sensitive to inhibition by tryptophan. Mutant strains of E. coli have been isolated in which DAHP synthetase (trp) is feedback-resistant.
The first reaction of aromatic biosynthesis, the conversion of erythrose-4-phosphate and phosphoenolpyruvate to 3-deoxy-D-arabinoheptulosonic acid-7-phosphate (DAHP), is carried out in Escherichia coli by three isoenzymes (4, (10) (11) (12) . The formation of each one of these isoenzymes is repressed by one of the three aromatic amino acids as follows. The formation of DAHP synthetase (tyr) is repressed by tyrosine, DAHP synthetase (phe) by phenylalanine, and DAHP synthetase (trp) by tryptophan. In addition, the activities of DAHP synthetase (phe) and DAHP synthetase (tyr) are feedback-inhibited by phenylalanine and tyrosine, respectively. The failure to observe any significant inhibition of DAHP synthetase (trp) in E. coli by tryptophan has been reported from a number of laboratories (4, 8, 11) . One exception to this is a recent report by Doy (6) of 32% inhibition of DAHP synthetase (trp) in extracts of E. coli W. There are reasons, however, why in vitro tests for inhibition of this enzyme have been difficult to carry out. In wild-type E. coli, DAHP synthetase (trp) is produced in much smaller amounts than either DAHP synthetase (tyr) or DAHP synthetase (phe), and it can only be identified as that activity not inhibited by either phenylalanine or tyrosine. Consequently, it is necessary to study the inhibition of a very small fraction of the total activity. Furthermore, tryptophan in concentrations of 5 X 10-4 M or more interferes with the colorimetric test for the assay of DAHP. Although it is possible to measure the extent of this interference by carrying out appropriate controls, this adds an extra element of uncertainty to any small inhibitions that are observed. It is the purpose of this communication to describe in vivo and in vitro experiments which do, however, clearly demonstrate that DAHP synthetase (trp) is inhibited by tryptophan in E. coli K-12.
MATERIALS AND METHODS
Organisms. The strains used in this work (Table   1 ) are all derivatives of E. coli K-12.
Media and culture methods. The media and culture methods used in this work were described by Adelberg The following symbols stand for structural genes concerned with various biosynthetic pathways: aro, the biosynthesis of chorismic acid; trp, tryptophan biosynthesis; thi, thiamine biosynthesis; his, histidine biosynthesis; pro, proline biosynthesis; arg, arginine biosynthesis; ilv, isoleucine and valine biosynthesis; leu, leucine biosynthesis. aroB, is the structural gene for DHQ synthetase; aroF is the structural gene for DAHP synthetase (tyr); aroG, is the structural gene for DAHP synthetase (phe); and aroH, is the structural gene for DAHP synthetase (trp). 6 Numbers refer to allele numbers allotted to mutant strains in this laboratory.
0.5 ml of cold 10% trichloracetic acid. The precipitate was removed by centrifugation and 0.4 ml of the supernatant fluid was used in the assay for DAHP and DAH (the dephosphorylated form of DAHP). Estmation of DAHP and DAH. The method described by Brown and Doy was used (4) . The effect of tryptophan on the development of the chromogen was tested as follows. Immediately prior to the addition of periodate, suitable concentrations of tryptophan were added to samples in which tryptophan had not been present either during the accumulation or during the period of enzyme reaction. The optical density readings obtained with these tubes were compared with results from similar tubes to which no tryptophan had been added. Final readings were corrected for any effects of tryptophan on the actual colorimetric assay.
Assay of DAHP synthetase. The method described by Doy and Brown (7) was used except that CO2+ was added to the reaction mixture at a final concentration of 10-3 M.
Isolation of mutants. The conditions under which cells were treated with the mutagen N-methyl-N'-nitro-N-nitrosoguanidine were those described by Adelberg, Mandel, and Chen (2).
Preparation of cell-free extracts. The conditions under which cell-free extracts were prepared by use of the French Press to break the cells has been described previously (9) .
Sonic treatment of cell suspensions. Cells were suspended in 0.1 M phosphate buffer (pH 7.0) to a final concentration of approximately 1010 cells per ml and were sonically treated for 40 sec using an MSE ultrasonicator. RESULTS Strain AB2891 possesses only a single isoenzyme, DAHP synthetase (trp), and will not grow in minimal medium supplemented with tryptophan unless phenylalanine and tyrosine are also added (12 Effect of tryptophan on the accumulation of DAHP. To confirm that the inhibitory effect of tryptophan on the growth of JP62 was a result of the inhibition of DAHP synthetase activity, an aroB-mutation affecting the enzyme converting DAHP to dehydroquinate was introduced into JP62. The recombinant strain which possesses the mutant alleles aroF363, aroG365, aroB351, and trpR363 is JP65. When cell suspensions of JP65 are washed and incubated at 37 C in minimal medium that does not contain the aromatic amino acids, DAHP and its dephosphorylated derivative DAH [DAH(P)] are accumulated and excreted by the cells (12) . The formation of DAH(P) by these cells depends entirely on the activity of DAHP synthetase (trp) which is being produced constitutively. Therefore, the effect of added tryptophan on the accumulation of DAH(P) by these cells was studied to determine whether DAHP synthetase (trp) was feedbackinhibited in vivo. The results indicated that the addition of L-tryptophan (5 x 10-4 M) at time zero causes an 80% decrease in the rate at which DAH(P) accumulates (Fig. 1) . Cell suspensions were sonically treated (at zero-time and at 120 min) and assayed for DAHP synthetase activity. The amount of DAHP synthetase activity did not increase during the 120 min, and the level of activity found in cells incubated in the presence of tryptophan was the same as that found in cells incubated in the absence of tryptophan, confirming that no significant repression or derepression of DAHP synthetase occurred during the course of the experiment. Both growth tests and accumulation studies, therefore, clearly indicate that tryptophan can inhibit the activity of DAHP synthetase (trp).
Isolation of feedback-resistant mutants. Further evidence to support the conclusion that DAHP synthetase (trp) is inhibitable by tryptophan comes from a study of mutant strains derived from AB2891 and able to grow in the presence of tryptophan. Strain AB2891 was treated with nitrosoguanidine, and the survivors were plated to minimal medium containing 5 X 10-4 M L-tryptophan. Only those colonies which grew on this medium and which were still unable to make either functional DAHP synthetase (tyr) or DAHP synthetase (phe) were examined further. Some of these mutants, although able to grow in the presence of added tryptophan, did show a reduction in growth rate when tryptophan was added to the medium. Strain JP66 is an example of such a mutant strain. Other strains showed no reduction in growth rate (J. Pittard and J. Camakaris, in preparation). Strain JP66 grows more quickly than AB2891 in minimal medium (mean generation time of 87 min compared to 180 min; Table 2 ). When tryptophan is added to the minimal medium, however, strain AB2891 will not grow at all, whereas strain JP66 grows with a mean generation time that is only approximately 1.5 times longer than that observed in minimal medium. The growth rate of a trpR363 derivative of JP66, JP68, is also included in Table  2 . It is interesting to note that with this strain the addition of tryptophan to minimal medium does not cause any decrease in growth rate, whereas in the case of the trpR363 derivative of AB2891, JP62, the addition of tryptophan changes the mean generation time from 180 to 720 min. The addition of all the aromatic amino acids plus shikimate to the medium causes these four strains to grow at a normal rate. Enzymic studies of JP66 failed to show any alteration to the repressibility of DAHP synthetase (trp) in this organism, indicating that its ability to grow in the presence of tryptophan did not result from any change in repressibility of DAHP synthetase (trp). The DAHP synthetase activities in cell-free extracts prepared from both JP66 and AB2891 grown in the presence and in the absence of aromatic amino acids are shown in Table 3 . The failure to demonstrate any change in repression of DAHP synthetase (trp) in JP66 suggests that its ability to grow in the presence of tryptophan may result from a change in the feedback sensitivity of this enzyme.
Map location of the mutation confirming tryptophan resistance to strain JP 66. If the mutation which enables JP66 to grow in the presence of tryptophan is affecting the structure of DAHP synthetase (trp), it should map within the structural gene for this enzyme, aroH. Preliminary experiments to see whether this mutation was cotransducible with aroH were carried out as follows. Strain AB2891 has the genotype aroF363, aroG365, aroH+ for the three structural genes for the DAHP synthetase isoenzymes. Strain JP66 is isogenic with AB2891, except that it may contain a mutation in the aroH gene which renders DAHP synthetase (trp) feedback-resistant. Strain AB3248 has the genotype aroF363, aroG365, aroH367 and requires the aromatic amino acids for growth since it cannot make functional DAHP synthetase. In a phage Plmediated transduction experiment in which AB3248 is the recipient (either AB2891 or JP66 are the donors) and in which transductants are selected on minimal medium not containing aromatic amino acids, selection is being made for the transfer of the aroH gene. If the aroH gene of strain JP66 carries a mutation which causes feedback-resistant DAHP synthetase (trp) to be formed, nearly all the transductants from the cross in which JP66 is the donor should be able to grow in the presence of added tryptophan. On the other hand, none of the transductants from the cross in which AB2891 is the donor would be expected to grow on this medium. When these experiments were carried out, at least 90% of the transductants obtained with JP66 as donor were able to grow in the presence of tryptophan. No transductants with this property were obtained, however, from the transduction in which AB2891 was the donor. Although these results do not prove that the mutation causing tryptophan resistance is located within the gene aroH, the close linkage between the two supports this conclusion.
Effect of tryptophan on the accumulation of DAH(P) by feedback-resistant strains. Both the aroB351 and the trpR363 mutations were introduced into strain JP66 to make a recombinant strain JP69, which is identical with JP65 except for the mutation in the aroH gene conferring feedback resistance. Accumulations were carried out, as they were for JP65, in the presence and in the absence of added tryptophan (Fig. 2) . In this case, the addition of tryptophan had no effect on the accumulation of DAH(P), confirming the conclusion that DAHP synthetase (trp) made by strain JP66 is feedback-resistant.
One other strain isolated from AB2891 is JP70. This strain produces DAHP synthetase (trp) constitutively. Since its growth rate is not affected by tryptophan, its DAHP synthetase (trp) activity is presumably also feedback-resistant. Accumulation studies were carried out with an aroB351 derivative of JP70. The results confirmed the conclusion that the DAHP synthetase (trp) made by this strain is also feedback-resistant (Fig. 3) .
In vitro inhibition of DAHP synthetase (trp). By working with strain AB2891, it is possible to study the characteristics of DAHP synthetase (trp) in crude cell-free extracts. We have found that upon incubation with ethylenediaminetetraacetate (EDTA), cell-free extracts of this strain lose all DAHP synthetase activity. The addition of Co2+ (10-8 M, as sulphate) restores this activity to a value twice the initial value obtained in the absence of EDTA. The addition of Co2+ (10-3 M) to crude cell-free extracts to which no EDTA has been added also causes an approximate twofold increase in activity. Furthermore, when these extracts are titrated for sensitivity to tryptophan in the presence of Co2+, it is possible to demonstrate feedback inhibition (Fig. 4) . Included in this figure are two titrations carried out on the two feedback-resistant strains, JP65 and JP70. The DAHP synthetase produced by these strains is much less sensitive to tryptophan, particularly at lower levels of inhibitor concentration. The largest inhibition of wild-type DAHP synthetase (trp) that was observed was 60% (in the presence of Co2+ and using L-tryptophan at a concentration of 10-8 M). In the absence of added Co2+, an inhibition of 20% was observed with this concentration of L-tryptophan. DISCUSSION These results clearly indicate that DAHP synthetase (trp) of E. coli K-12 is inhibited by tryptophan in vivo. When Co2+ is added to the reaction mixture, it is also possible to demonstrate inhibition of this enzyme activity in vitro. The addition of Co2+ stimulates DAHP synthetase (trp) activity in cell-free extracts and reveals its sensitivity to inhibition by tryptophan. Because, however, Co2+ does not have to be added in order to show inhibition in vivo, its effect in the in vitro experiments is presumably to correct some alteration to enzyme conformation or state of aggregation which has occurred during the preparation of cell-free extracts. Neither in vivo nor in vitro tests have revealed more than an 80% inhibition of enzyme activity.
Mutant strains with a feedback-resistant DAHP synthetase (trp) have been isolated. Some of these are also derepressed for the enzyme DAHP synthetase (trp), whereas others show normal repressibility. In the case of the strains that are both derepressed and feedback-resistant, it has not yet been possible to determine whether these changes are the result of one or two mutations occurring in the aroH gene.
